Omalizumab for Treatment of Anti-GD2 Antibody-related Urticaria.
Glincher R, Lentini-Rivera A, Andre Jones L, D'Andrea L, Durney C, Kasper C, Lin Y, Shrager L, Markova A, Lacouture M, Modak S.
Glincher R, et al. Among authors: kasper c.
J Pediatr Hematol Oncol. 2024 Oct 1;46(7):e531-e533. doi: 10.1097/MPH.0000000000002939. Epub 2024 Aug 22.
J Pediatr Hematol Oncol. 2024.
PMID: 39177945